Effect of postmenopausal hormone therapy on cardiovascular risk

Journal of Hypertension

Volumn 20, Issue SUPPL. 2, 2002, Pages

  Rossouw, Jacques E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Coronary heart disease; Estrogen; Hormone replacement therapy; Stroke

Indexed keywords

ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE; PROGESTERONE DERIVATIVE;

CARDIOVASCULAR RISK; CONFERENCE PAPER; FEMALE; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; STROKE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; ESTROGEN THERAPY; REVIEW; RISK FACTOR; TREATMENT OUTCOME; WOMEN'S HEALTH;

BIAS (EPIDEMIOLOGY); CLINICAL TRIALS; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MEDROXYPROGESTERONE; PROGESTERONE CONGENERS; RISK FACTORS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 0036562937     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200212000-00001     Document Type: Conference Paper

References (25)

1. Randomized trial of estrogen plus progestin for secondary prevention in postmenopausal women
2. Postmenopausal hormones and recurrence of coronary events in the Nurses' Health Study
3. Effects of estrogen replacement on the progression of coronary artery atherosclerosis
4. Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence. Correlation with plasma testosterone levels
5. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies
6. What we still need to learn about hormone replacement therapy
7. Menopause and the risk of coronary disease in women
8. Hormone replacement therapy, heart disease, and other considerations
9. Post-menopausal estrogen and progestin use and the risk of cardiovascular disease
10. Prior to use of estrogen replacement therapy, are users healthier than non-users?
11. Treatment adherence and risk of death after a myocardial infarction
12. Postmenopausal hormone therapy and mortality
13. Evidence of a healthy estrogen user survivor effect
14. The protective effects of estrogen on the cardiovascular system
15. Effects of tibolone and continuous combined hormone replacement therapy on parameters of the clotting cascade: Multicenter, double-blind, randomized study
16. Impaired procoagulant-anticoagulant balance during hormone replacement therapy? A randomized, placebo-controlled 12-week study
17. Effect of postmenopausal hormones on inflammation-sensitive proteins: The Postmenopausal Estrogen/Progestin Interventions (PEPI) study
18. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism
19. Comparison of transdermal and and oral estrogen-progestin replacement: Effects on serum lipids and lipoproteins
20. The metabolic consequences of treating post-menopausal women with non-oral hormone replacement therapy
21. Effects of oral and transdermal hormone replacement therapy on lipoprotein (a) and lipids: A randomized controlled trial
22. The effects of transdermal estradiol and oral conjugated estrogens on hemostasis variables
23. Effects of oral and transdermal estrogen/progesterone concentrations on blood coagulation and fibrinolysis in postmenopausal women. A randomized controlled trial
24. Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women